NCT03716674
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
Not specified
Clinical trial condition
Synucleinopathies
Explore clinical trials studying Synucleinopathies. Study availability and eligibility vary by location and protocol.
3,501 public trials
646 recruiting studies
Synucleinopathies trial results
NCT03116295
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Nuvisan GmbH Neu-Ulm, Germany
Completed
Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)
NCT02657681
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +17 more
- Locations
-
- CINAC, Hospital Universitario Puerta del Sur Móstoles, Madrid, Spain
NCT02599753
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Chang Gung Memory Hospital Taoyuan, Taiwan
NCT02059733
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Chang Gung Memory Hospital Taoyuan, Taiwan
NCT02925065
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Johns Hopkins University (Peabody Institute & Department of Neurology) Baltimore, Maryland, United States
NCT01323855
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
Not specified
NCT02318927
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- University of Florida Center for Movement Disorders and Neurorestoration Gainesville, Florida, United States
Completed
Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)
NCT00434304
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- GSK Investigational Site Aichi, Japan
- GSK Investigational Site Aichi, Japan
- GSK Investigational Site Chiba, Japan
- GSK Investigational Site Ehime, Japan
Completed
Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.
NCT02750982
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Amyotrophic Lateral Sclerosis, +46 more
- Locations
-
- Evergreen Healthcare Kirkland, Washington, United States